SCHEMBL27663136

SCHEMBL27663136

Cn1ccc(N)c1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.57
CA1 P00915 1/20 0.57
CA2 P00918 1/20 0.57
CA9 Q16790 1/20 0.57
KDR P35968 13/20 0.56
PDGFRB P09619 6/20 0.55
RIPK1 Q13546 2/20 0.54
FLT3 P36888 6/20 0.53
RET P07949 3/20 0.53
AURKB Q96GD4 2/20 0.53
NTRK1 P04629 2/20 0.53
NTRK3 Q16288 2/20 0.53
NTRK2 Q16620 2/20 0.53
LTK P29376 1/20 0.53
CDK8 P49336 1/20 0.53
MAPK14 Q16539 1/20 0.53
KIT P10721 6/20 0.52
FLT1 P17948 5/20 0.52
CSF1R P07333 4/20 0.52
FLT4 P35916 4/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27682740 0.84 KDR (0.57) KDRRIPK1FLT3RETAURKB
SCHEMBL27663133 0.83 RIPK1 (0.52) CA12CA1CA2CA9KDR
SCHEMBL28078227 0.78 CA12 (0.60) CA12CA1CA2CA9KDR
SCHEMBL13541769 0.77 CA12 (0.69) CA12CA1CA2CA9KDR
SCHEMBL21750852 0.76 CA12 (0.70) CA12CA1CA2CA9KDR
SCHEMBL4260549 0.75 RET (0.57) CA12CA1CA2CA9KDR
SCHEMBL5341416 0.75 KDR (0.68) CA12CA1CA2CA9KDR
SCHEMBL4340395 0.75 CA12 (0.69) CA12CA1CA2CA9KDR
SCHEMBL24710550 0.75 FLT1 (0.67) KDRPDGFRBRIPK1FLT3RET
SCHEMBL31000858 0.75 FLT1 (0.67) KDRPDGFRBRIPK1FLT3RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1993361-B Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis BAYER PHARMACEUTICALS CORP 2010-05-26 CN disclosed
CN-1993361-A Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis BAYER PHARMACEUTICALS CORP (US) 2007-07-04 CN disclosed